Bioequivalence of Burophil Capsule to Surfolase Capsule (Acebrophylline 100 mg) |
Cho, Hea-Young
(College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Park, Eun-Ja (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Kang, Hyun-Ah (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Kim, Se-Mi (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Park, Chan-Ho (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Oh, In-Joon (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Lim, Dong-Koo (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Lee, Myung-Hee (Kwangju Christian Hospital) Lee, Yong-Bok (College of Pharmacy, Institute of Bioequivalence and Bridging Study, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) |
1 | F. Scaglione, S. Dugnani, G Maccarinelli and F. Fraschini, Effect of acebrophylline on the content and composition of the lipids forming the pulmonary surfactant, Italian J. Chest Diseases, supplement, 67-72 (1992) |
2 | L.D. Angelo, Plasma levels and pharmacokinetic parameters of ambroxol and theophylline-7-acetic acid in adults after single and repeated acebrophylline doses, Italian J. Chest Diseases, 5(1), 85-89 (1992) |
3 | 현대약품공업(주) 발행, Sulfolase 캅셀, 7-8 (1998) |
4 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22) |
5 | 식품의약품안전청 고시 제 1999-67호, 의약품임상시험관리기준 (2000. 1. 4) |
6 | L. Colombo, F. Marcucci, M.G Marini, P. Pierfederici and E. Mussini, Determination of ambroxol in biological material by gas chromatography with electron-capture detection, J. Chromatogr., 530(1), 141-147 (1990) DOI ScienceOn |
7 | Statistical Solutions Ltd., Equiv 2.0, UK (2001) |
8 | Food and Drug Administration (FDA): Guidance for Industry; Waiver of in vivo bioavailability and bioequivalence study for immediate-release solid oral dosage forms based on a biopharmaceutics classification system, Center for Drug Evaluation and Research (CDER), August (2000) |
9 | H.J. Lee, S.K. Joung, Y.G. Kim, H.Y Yoo and S.B. Han, Bioequivalence assessment of ambroxol tablet after a single oral dose administration to healthy male volunteers, Pharmacological reserch, 49, 93-98 (2004) DOI ScienceOn |
10 | M.H.A. Botterblom, T.J. Janssen, P.J.M. Guelen, Rapid and sensitive determination of ambroxol in human plasma and urine by high-performance liquid chromatography, J. Chromatogr., 421, 211-215 (1987) DOI ScienceOn |
11 | F.J. Flores-Murrieta, C. Hoyo-Vadillo, E. Hong and G Castaneda-Hernandez, Assay of ambroxol in human plasma by high-performance liquid chromatography with amperometric detection, J. Chromatogr. , 490, 464-469 (1989) DOI ScienceOn |